Health insurers and the companies they hire to manage pharmaceutical benefits are reporting early success in efforts to better manage access to opioid medications.
OptumRx, which is the pharmaceutical benefits manager at Minnetonka-based UnitedHealth Group, said this week that a pilot program has helped reduce inappropriate consumption of opioid painkillers at the heart of an addiction and overdose epidemic.
Indianapolis-based Anthem Inc., one of the nation's largest insurers, as well as pharmaceutical benefit manager Express Scripts, which is based in St. Louis, have reported results this summer that suggest insurance company programs can help control the supply of prescription opioids in beneficial ways.
Doctors have expressed some concerns about the trend nationally, warning that one-size-fits-all approaches might actually harm patients. But Dr. Beth Averbeck with Bloomington-based HealthPartners said insurers and health care providers can collaborate in beneficial ways to tackle the opioid crisis.
"We need to partner on this together, to be able to address it and come up with better alternatives for our patients and members," said Averbeck, who is the health system's senior medical director for primary care.
Opioids can be prescribed by doctors to treat moderate to severe pain, but can also have serious risks and side effects, according to the Centers for Disease Control and Prevention (CDC).
In 2013, health care providers wrote nearly a quarter of a billion opioid prescriptions, according to the CDC, with common types including oxycodone (OxyContin), hydrocodone (Vicodin), morphine and methadone. Studies suggest that as many as 1 in 4 patients receiving long-term opioid therapy in a primary care setting struggles with opioid addiction.
Nearly 2 million Americans either abused or were dependent on prescription opioid pain relievers in 2014, the CDC said, adding that taking too many prescription opioids can be deadly.